You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chidamide

Showing 1 - 25 of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral T Cell Lymphoma, Epigenetic Repression Trial in Tianjin (Chidamide, Azacitidine)

Recruiting
  • Peripheral T Cell Lymphoma
  • Epigenetic Repression
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 14, 2023

First-line Maintenance Treatment of PTCL With Chidamide.

Recruiting
  • PTCL
  • chidamide
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Jul 23, 2023

Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Suzhou (Selinexor, Chidamide)

Recruiting
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 16, 2023

Acute Lymphoblastic Leukemia Trial (chidamide, Venetoclax Oral Tablet, Inotuzumab Ozogamicin)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • chidamide
  • +2 more
  • (no location specified)
Oct 19, 2023

HR Positive HER2 Negative Advanced Breast Cancer Trial in Tianjin (Chidamide)

Recruiting
  • HR Positive HER2 Negative Advanced Breast Cancer
  • Chidamide
  • Tianjin, China
    天津市肿瘤医院
May 26, 2023

T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • Chidamide
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 7, 2023

Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)

Recruiting
  • Leukemia, Myeloid, Acute
  • Chidamide
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Dec 27, 2022

DLBCL Trial in Suzhou (Chidamide, Azacitidine, obinutuzumab)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Chidamide
  • +3 more
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Apr 10, 2023

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Breast Cancer, Chemo Effect Trial in Beijing (Chidamide)

Recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Chidamide
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 17, 2023

Chidamide in Recurrent and Refractory Diffuse Large b

Enrolling by invitation
  • Diffuse Large B-cell Lymphoma
  • Chidamide
  • +2 more
  • Suzhou, Jiangsu, China
    Second Affiliated Hospital of Soochow University
Jan 9, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

Relapsed or Refractory Peripheral T-cell Lymphoma Trial in Taiwan (Chidamide)

Not yet recruiting
  • Relapsed or Refractory Peripheral T-cell Lymphoma
  • Chidamide
  • Kaohsiung, Taiwan
  • +4 more
Apr 17, 2023

Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype Trial in Guangzhou (Chidamide combined with CHOP,

Recruiting
  • Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
  • Chidamide combined with CHOP
  • Chidamide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University
Oct 7, 2022

HR+/HER2- Advanced Breast Cancer Trial in Beijing (Dalpiciclib, Chidamide)

Not yet recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Beijing, Beijing, China
    The Fifth Medical Center of PLA General Hospital
Oct 17, 2022

Breast Cancer Trial in Shanghai (Chidamide, Abemaciclib, Fulvestrant)

Recruiting
  • Breast Cancer
  • Chidamide
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 31, 2022

HIV-1 Infection Trial in Kaohsiung City, Taiwan (UB-421, chidamide)

Recruiting
  • HIV-1 Infection
  • UB-421
  • chidamide
  • Kaohsiung City, Taiwan, Taiwan
    Kaohsiung Veterans General Hospital
Aug 25, 2022

Acute Monocytic Leukemia, Newly Diagnosed Trial in Suzhou (Chidamide, Azacitidine, Venetoclax)

Recruiting
  • Acute Monocytic Leukemia
  • Newly Diagnosed
  • Chidamide
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Oct 3, 2022

Thrombocytopenia Trial (Chidamide, HD-DXM)

Not yet recruiting
  • Thrombocytopenia
  • (no location specified)
Jun 6, 2022

Acute Myeloid Leukemia Trial in Nanjing (Chidamide, Cladribine)

Recruiting
  • Acute Myeloid Leukemia
  • Nanjing, Jiangsu, China
    Department of Hematology, Zhongda Hospital Southeast University,
Apr 23, 2022

Peripheral T-cell Lymphoma Targeted Therapy Trial in Tianjin (Azacitidine, Chidamide, Cyclophosphamide)

Enrolling by invitation
  • Peripheral T-cell Lymphoma Targeted Therapy
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute & Hospital
Jan 9, 2023

Triple-negative Breast Cancer Trial in Shanghai (chidamide, camrelizumab, carboplatin)

Not yet recruiting
  • Triple-negative Breast Cancer
  • chidamide
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 25, 2022

Non-hodgkin's Lymphoma Trial in Beijing (Chiauranib, Chidamide)

Completed
  • Non-hodgkin's Lymphoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 7, 2022

Metastatic Colorectal Cancer Trial in New Taipei City (chidamide, celecoxib)

Recruiting
  • Metastatic Colorectal Cancer
  • New Taipei City, Taiwan
    Taipei Medical University Shuang Ho Hospital
Mar 4, 2022

Relapsed/Refractory Non-Hodgkin Lymphoma, Advanced Solid Tumors Trial in Beijing (Chidamide, Decitabine, Immune checkpoint

Recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Advanced Solid Tumors
  • Chidamide
  • +2 more
  • Beijing, Beijing, China
    Biotherapeutic Department, Chinese PLA General Hospital
Apr 8, 2022